ArticleNature communications2026
Portable hip exoskeleton improves walking economy for stroke survivors.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biomechanical energy harvesting to improve post-stroke mobility.Nature communications · 2026Article
- Exoskeleton frontal and sagittal plane hip torque improves propulsion and transient stability during walking in individuals with hemiparesis.Journal of neuroengineering and rehabilitation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Increased metabolic cost of walking after stroke limits mobility and quality of life for millions of individuals. Existing portable assistive devices, primarily targeting the ankle joint, have failed to alleviate this burden. Here, we tested a portable, lightweight hip exoskeleton providing bilateral assistance during walking for individuals with chronic post-stroke hemiparesis. The exoskeleton significantly reduced the net metabolic cost of walking by 18 ± 2% (mean ± standard error, p = 0.0002) in seven participants during treadmill walking-a reduction sufficient to potentially lessen fatigue and extend walking duration- compared to walking without the device. This improvement was associated with a 29 ± 6% reduction in positive biological hip work (p = 0.0052), indicating effective offloading of the hip joints. These results provide the first evidence that portable hip exoskeleton assistance can improve walking economy in stroke survivors, offering a promising therapeutic strategy to enhance real-world mobility and functional recovery in this large clinical population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.